Results 151 to 160 of about 824,117 (206)

CCR5 Antagonist and Agonist Binding Site Structures

Retrovirology, 2005
Mills John, Grieco Paul, Wilkinson Royce, Teintze Martin, Dratz Edward   +4 more
doaj   +1 more source

Maraviroc, a CCR5 antagonist, ameliorates the development of hepatic steatosis in a mouse model of non-alcoholic fatty liver disease (NAFLD).

Journal of Antimicrobial Chemotherapy, 2014
L. Perez-Martinez, P. Pérez-Matute, J. Aguilera-Lizarraga, S. Rubio-Mediavilla, J. Narro, E. Recio, L. Ochoa-Callejero, J. Oteo, J. Blanco   +8 more
semanticscholar   +1 more source

Effect of the CCR5 antagonist maraviroc on the occurrence of immune reconstitution inflammatory syndrome in HIV (CADIRIS): a double-blind, randomised, placebo-controlled trial.

The Lancet HIV, 2014
J. Sierra-Madero, S. Ellenberg, M. Rassool, A. Tierney, Pablo F Belaunzarán-Zamudio, Alondra López-Martínez, A. Piñeirúa-Menéndez, L. Montaner, L. Azzoni, César Rivera Benítez, I. Sereti, J. Andrade-Villanueva, J. Mosqueda-Gómez, B. Rodriguez, I. Sanne, M. Lederman   +15 more
semanticscholar   +1 more source

Efficacy of the CCR5 Antagonist Maraviroc in Reducing Early, Ritonavir-Induced Atherogenesis and Advanced Plaque Progression in Mice

Circulation, 2013
S. Cipriani, D. Francisci, A. Mencarelli, B. Renga, E. Schiaroli, Claudio D'Amore, F. Baldelli, S. Fiorucci   +7 more
semanticscholar   +1 more source

CCR5 and CXCR4 antagonist and agonist binding sites

Retrovirology, 2006
Dratz Edward, Mills John, Grieco Paul, Wilkinson Royce, Teintze Martin   +4 more
doaj   +1 more source

Reduced Maximal Inhibition in Phenotypic Susceptibility Assays Indicates that Viral Strains Resistant to the CCR5 Antagonist Maraviroc Utilize Inhibitor-Bound Receptor for Entry

Journal of Virology, 2006
M. Westby, C. Smith-Burchnell, Julie Mori, Marilyn Lewis, Mike Mosley, M. Stockdale, P. Dorr, G. Ciaramella, M. Perros   +8 more
semanticscholar   +1 more source

Emerging CCR5-Based Therapeutic Potential of JAK/STAT Inhibitors and CCR5Δ32 Hematopoietic Stem Cell Transplantation. [PDF]

Viruses
Khalid K, Iqbal U, Shaltout M, Yukselten Y, Ahmad F, Khalid AR, Sutton RE.   +6 more
europepmc   +1 more source

Identification of Isoliensinine as a Novel CCR5 Inhibitor for the Prevention of Skeletal Muscle Atrophy Through Virtual Screening and Experimental Validation. [PDF]

Molecules
Qu T, Chen Y, Zhang Y, Wang Y, Li Y, Sun Y.   +5 more
europepmc   +1 more source

The magnitude of HIV-1 resistance to the CCR5 antagonist maraviroc may impart a differential alteration in HIV-1 tropism for macrophages and T-cell subsets.

Virology, 2013
Jacqueline K. Flynn, G. Paukovics, Miranda S. Moore, Anne M. Ellett, L. Gray, R. Duncan, H. Salimi, B. Jubb, M. Westby, D. Purcell, S. Lewin, Benhur Lee, Melissa J. Churchill, P. Gorry, Michael Roche   +14 more
semanticscholar   +1 more source

The chemokine network in lupus nephritis: pathogenesis, targeted therapies, and future directions. [PDF]

Front Pharmacol
Wang C, Chen L.
europepmc   +1 more source